U.S. Water Utilities Stock News

NasdaqGS:OSBC
NasdaqGS:OSBCBanks

Old Second Bancorp (OSBC) Valuation Check After Q1 2026 Earnings And Higher Credit Costs

Q1 2026 earnings event reshapes the story Old Second Bancorp (OSBC) just posted Q1 2026 results that combine higher net income, a completed acquisition that expanded assets and footprint, and a clear rise in credit costs tied to problem loans. See our latest analysis for Old Second Bancorp. At a share price of $21.08, Old Second Bancorp has a year to date share price return of 8.21%. Its 1 year total shareholder return of 27.57% and 3 year total shareholder return of 95.98% point to momentum...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Three Founder Led Stocks With Premium Brands And Hidden Firepower

With inflation readings still elevated in many countries, bond yields reacting to every policy hint and trade flows shifting across regions, it is easy to feel stuck on the sidelines. One way to cut through the noise is to focus on founder-led companies where leadership has real skin in the game and capital is used carefully. This screener does exactly that, filtering for businesses where founders are still in charge and closely aligned with shareholders. In this article, you will see three...
NYSE:ATMU
NYSE:ATMUMachinery

Atmus Filtration Technologies (ATMU) Valuation After Strong Q1 2026 Results And Reaffirmed Earnings Guidance

Atmus Filtration Technologies (ATMU) is back in focus after reporting first quarter 2026 results, with higher sales and net income than a year ago, and reaffirmed full year 2026 earnings guidance. See our latest analysis for Atmus Filtration Technologies. The reaffirmed 2026 guidance and recent buyback activity come against a mixed trading backdrop, with a 1 day share price return of 1.09%, a 7 day share price decline of 13.50%, a year to date share price return of 4.64%, and a 1 year total...
NYSE:DFIN
NYSE:DFINCapital Markets

Is Donnelley Financial (DFIN) Balancing Softer Guidance With a Stronger Software Story?

Donnelley Financial Solutions recently reported first-quarter 2026 results showing revenue of US$205.5 million and net income of US$33.5 million, with earnings per share rising year on year. The company also issued second-quarter sales guidance and highlighted growing demand for its software platforms as clients adapt to evolving SEC reporting rules. Now we will examine how this earnings update and softer revenue guidance may influence Donnelley Financial Solutions’ existing investment...
NasdaqGS:ALKS
NasdaqGS:ALKSBiotechs

Evaluating Alkermes (ALKS) Valuation After Recent Share Price Momentum

Context for Alkermes stock Alkermes (ALKS) has been on investors’ radar after recent share price moves, with the stock showing gains over the past week, month, and past 3 months that stand out against its longer term return profile. With the company valued at about US$5.9b and reporting revenue of US$1.6b and net income of US$152.7m, many investors are now focusing on whether the current valuation still reflects its fundamentals. See our latest analysis for Alkermes. At the current share...
NasdaqGM:VITL
NasdaqGM:VITLFood

A Look At Vital Farms (VITL) Valuation After Q1 2026 Loss, Outlook Cut And Butter Exit

Vital Farms (VITL) has drawn fresh investor attention after Q1 2026 results showed sales of US$187.16 million, alongside a net loss, a lower full year outlook, and a planned exit from its butter business. See our latest analysis for Vital Farms. The share price reaction has been severe, with a 1 day share price return of 20.7% and a year to date share price return of 68.1%. At the same time, the 1 year total shareholder return of 70.8% and 5 year total shareholder return of 52.2% point to...
NYSE:UTZ
NYSE:UTZFood

Evaluating Utz Brands (UTZ) Valuation After Recent Share Price Weakness

What recent performance suggests about Utz Brands (UTZ) Utz Brands (UTZ) has been on investors’ radars after a mixed run, with the stock roughly flat over the past month but showing a return decline over the past 3 months and past year. At a last close of US$7.72 and a market cap of about US$1.19b, the company sits in an interesting spot for snack sector investors who are weighing current pricing against its recent performance profile. See our latest analysis for Utz Brands. For context, Utz...
NasdaqGS:EYE
NasdaqGS:EYESpecialty Retail

Did Wall Street’s Q1 2026 Expectations Just Reframe National Vision Holdings’ (EYE) Investment Narrative?

National Vision Holdings is set to report its Q1 2026 results on May 13, with Wall Street expecting earnings per share of US$0.43 and revenue growth alongside higher comparable store sales. Analysts are watching for signs of improved operating leverage and margin performance, as well as how management characterizes consumer demand and competition across its optical retail formats. With expectations for higher earnings and mid-single-digit revenue growth, we'll examine how this upcoming...
NasdaqGS:SGRY
NasdaqGS:SGRYHealthcare

A Look At Surgery Partners (SGRY) Valuation After Reaffirmed Guidance And Positive First Quarter Results

Key earnings takeaways for Surgery Partners (SGRY) Surgery Partners (SGRY) kicked off 2026 with first quarter results that paired revenue growth with a narrower loss, while management reaffirmed full year guidance and highlighted ongoing cost discipline and portfolio work. The company reported Q1 revenue of US$810.9 million, basic and diluted loss per share from continuing operations of US$0.28, and an overall net loss of US$35.9 million. Management reiterated full year 2026 revenue guidance...
NYSE:NSA
NYSE:NSASpecialized REITs

Does NSA’s EPS Beat And Prudential Stake Increase Change The Bull Case For National Storage Affiliates Trust (NSA)?

National Storage Affiliates Trust recently reported past first quarter 2026 results, with revenue of US$185.4 million and net income rising to US$17.78 million, lifting diluted earnings per share from continuing operations to US$0.16. Alongside this, an updated filing showed Prudential Financial and its subsidiaries collectively hold about 1.8% of the company’s common stock, highlighting continuing institutional interest in the self-storage REIT. With higher earnings per share despite...
NasdaqGS:HLIT
NasdaqGS:HLITCommunications

Is Harmonic (HLIT) Offering Value After Strong Multi‑Period Share Price Gains?

If you are wondering whether Harmonic at US$12.28 is offering fair value or an opportunity, you will want to look past the headline share price and into what the valuation signals are really saying. The stock has recently shown sharp moves, with returns of 7.4% over the past week, 30.9% over the last 30 days, 22.6% year to date and 35.2% over the past year, set against a 22.8% decline over 3 years and a 78.2% gain over 5 years. Recent coverage around Harmonic has focused on its role as a...
NasdaqCM:INDI
NasdaqCM:INDISemiconductor

Assessing indie Semiconductor (INDI) Valuation After A 55% Monthly Share Price Surge

Stock performance context for indie Semiconductor indie Semiconductor (INDI) has drawn fresh attention after a strong month, with the stock returning about 55% over that period, while the past 3 months show a gain of roughly 14%. For readers watching shorter term swings, the move comes after a modest 1 day decline of about 2% and a flat week, which contrasts with a year total return of around 93% and a 3 year loss near 44%. See our latest analysis for indie Semiconductor. At a share price of...
NasdaqGS:SIMO
NasdaqGS:SIMOSemiconductor

Has Silicon Motion Technology (SIMO) Run Too Far After 368% One Year Surge?

Wondering whether Silicon Motion Technology's current share price matches its underlying worth, or if expectations have simply raced ahead of fundamentals. The stock last closed at US$242.71, with returns of 10.9% over 7 days, 107.4% over 30 days, 158.9% year to date and 368.2% over the past year. This puts valuation questions front and center. Recent coverage has focused on the stock's sharp gains and what they might signal about investor confidence and changing risk perception. This kind...
OTCPK:WBHC
OTCPK:WBHCBanks

Wilson Bank Holding (OTCPK:WBHC) Earnings Growth Reinforces Bullish Profitability Narratives

Wilson Bank Holding (WBHC) opened 2026 with Q1 revenue of US$60.8 million and basic EPS of US$1.82, while trailing 12 month revenue stood at US$229.8 million and EPS was US$6.73, supported by earnings growth of 35.6% over the past year. Over recent periods the company has seen revenue move from US$181.7 million and EPS of US$4.79 on a trailing 12 month basis at Q4 2024 to US$219.9 million and EPS of US$6.28 by Q4 2025. This sets up the latest quarter against a track record of expanding profit...
NYSE:EME
NYSE:EMEConstruction

EMCOR’s Inter Miami Deal Adds High Profile Twist To Valuation Debate

Hill York Service, an EMCOR Group subsidiary, has been selected as the official HVAC partner for Inter Miami CF's new Nu Stadium. The agreement covers HVAC systems for the new venue and aligns EMCOR with a high profile sports facility project. This development adds a fresh angle to the EMCOR story beyond recent attention on quarterly results and guidance. For investors tracking EMCOR Group (NYSE:EME), the Hill York Service partnership with Inter Miami CF comes on top of a stock that has...
NasdaqGM:BLZE
NasdaqGM:BLZEIT

Backblaze (BLZE) Valuation Check After Beat And Raise Earnings And AI Storage Optimism

Backblaze (BLZE) drew fresh attention after first quarter 2026 results, with revenue of US$38.67 million and a net loss of US$6.15 million, alongside higher full year revenue guidance. See our latest analysis for Backblaze. The beat and raise has been met with sharp buying interest, with Backblaze’s share price at US$7.50 and a 30 day share price return of 107.18%, while the 1 year total shareholder return sits at 42.86%. This suggests strong recent momentum on expectations for AI related...
NasdaqGS:AMLX
NasdaqGS:AMLXPharmaceuticals

Amylyx Readies Avexitide For PBH With Pivotal Trial And Valuation Gap

Amylyx Pharmaceuticals (NasdaqGS:AMLX) is advancing avexitide through the pivotal Phase III LUCIDITY trial for post-bariatric hypoglycemia (PBH). Pivotal Phase III data from LUCIDITY are expected next quarter. The company has also started a U.S. expanded access program so certain PBH patients can receive avexitide before any potential approval. Amylyx Pharmaceuticals focuses on therapies for serious neurological and metabolic conditions, with avexitide as its lead candidate for PBH. PBH can...
NYSE:GENI
NYSE:GENIHospitality

Genius Sports (GENI) Valuation Check After Q1 2026 Guidance Lift And Legend Acquisition

Genius Sports (GENI) stock was in focus after the company paired strong Q1 2026 revenue of US$187.95 million with a wider net loss and a sizeable guidance lift following the Legend acquisition. See our latest analysis for Genius Sports. The recent guidance lift and Legend acquisition came after a tough stretch for investors, with the share price down 55.66% year to date and the 1 year total shareholder return at a 53.23% loss. At the same time, the stock has posted a 13.00% 1 month share...
NasdaqCM:TSSI
NasdaqCM:TSSIIT

How Investors Are Reacting To TSS (TSSI) Revenue Drop Amid AI Integration Push And Steady EBITDA Outlook

TSS, Inc. reported past first-quarter 2026 results with revenue of US$55.35 million and net income of US$2.28 million, down from US$98.96 million and US$2.98 million a year earlier, alongside lower earnings per share. Despite lower headline revenue, management highlighted strong AI-driven systems integration activity, maintained its full-year adjusted EBITDA outlook, and reinforced its AI infrastructure focus with senior hires in strategy and technology. We’ll now examine how this AI-fueled...
NasdaqGM:TRUP
NasdaqGM:TRUPInsurance

A Look At Trupanion (TRUP) Valuation After First Quarter 2026 Earnings Turn To Net Income

Trupanion (TRUP) has moved into focus after reporting first quarter 2026 results, showing net income of US$4.88 million, compared with a net loss of US$1.48 million in the same period a year earlier. See our latest analysis for Trupanion. Recent trading reflects a mixed picture, with a 2.69% 1 day share price return and 6.67% 7 day share price return contrasting with a 31.21% year to date share price decline and a 41.92% 1 year total shareholder return decline. This suggests recent momentum...
NYSE:FLR
NYSE:FLRConstruction

Is It Too Late To Consider Fluor (FLR) After Its Strong One Year Rally?

For investors wondering whether Fluor stock still offers value after a strong run, or if most of the opportunity is already priced in, this article focuses squarely on what you are paying versus what you are getting. Fluor recently closed at US$51.08, with returns of 7.0% over 30 days, 22.5% year to date and 43.4% over 1 year. This puts its longer term 3 year and 5 year returns at 93.0% and 169.8% respectively. Recent coverage has highlighted Fluor's role as a large engineering and...